A Case Series of Lung Sequelae and Aspergillus Antigenemia: A Hidden Entity in Post-COVID-19 Critically ill Patients UR01-UR03
Dr. Sonali Banwait,
A-701, Delhi State Society, Plot No. 1, Sector-19, Dwarka, New Delhi, India.
Coronavirus Disease-2019 Associated Invasive Aspergillosis (CAPA) is a known entity with significant mortality. There is paucity of literature with secondary aspergillosis infection in post-COVID-19 patients. Serum galactomannan is a highly sensitive test for screening patients for Aspergillus antigenemia. Here, authors reported five post-COVID-19 patients with High Resolution Computed Tomography (HRCT) features and associated high risk factors for opportunistic aspergillosis (55-years-old-male, 46-years-old-male, 75-years-old-female, 55-years-old-female and 27-years-old-male) like prolonged intensive care stay, Acute Respiratory Distress Syndrome (ARDS), corticosteroid and broad spectrum antibiotic therapy like Meropenem, Colistin and Targocid etc.